Canaccord Genuity Group upgraded shares of Aurora Cannabis (TSE:ACB – Get Rating) from a sell rating to a hold rating in a research note published on Wednesday, BayStreet.CA reports. They currently have C$2.00 price target on the stock, down from their previous price target of C$2.50.
Other equities analysts have also recently issued research reports about the company. CIBC dropped their price objective on Aurora Cannabis from C$3.75 to C$2.50 in a report on Monday. Stifel Nicolaus upgraded Aurora Cannabis from a sell rating to a hold rating and lowered their target price for the stock from C$2.50 to C$2.15 in a report on Monday, June 6th. Cowen upped their target price on Aurora Cannabis from C$1.85 to C$2.00 in a report on Tuesday, July 19th. Cowen upped their target price on Aurora Cannabis from C$1.85 to C$2.00 in a report on Tuesday, July 19th. Finally, Piper Sandler lowered their target price on Aurora Cannabis to C$4.00 and set a neutral rating for the company in a report on Wednesday. One research analyst has rated the stock with a sell rating and eight have issued a hold rating to the stock. Based on data from MarketBeat.com, Aurora Cannabis has an average rating of Hold and an average target price of C$3.57.
Aurora Cannabis Price Performance
ACB opened at C$1.74 on Wednesday. The business has a fifty day moving average of C$1.98 and a 200 day moving average of C$2.86. Aurora Cannabis has a 52-week low of C$1.56 and a 52-week high of C$10.87. The company has a quick ratio of 3.95, a current ratio of 5.85 and a debt-to-equity ratio of 35.61. The stock has a market cap of C$518.08 million and a P/E ratio of -0.29.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- General Mills: Superior Returns With Less Volatility
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.